Model for End-Stage Liver Disease Score Predicts Left Ventricular Assist Device Operative Transfusion Requirements, Morbidity, and Mortality
Open Access
- 19 January 2010
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 121 (2) , 214-220
- https://doi.org/10.1161/circulationaha.108.838656
Abstract
Background— The Model for End-Stage Liver Disease (MELD) predicts events in cirrhotic subjects undergoing major surgery and may offer similar prognostication in left ventricular assist device candidates with comparable degrees of multisystem dysfunction. Methods and Results— Preoperative MELD scores were calculated for subjects enrolled in the University of Michigan Health System (UMHS) mechanical circulatory support database. Univariate and multiple regression analyses were performed to investigate the ability of patient characteristics, laboratory data (including MELD scores), and hemodynamic measurements to predict total perioperative blood product exposure and operative mortality. The ability of preoperative MELD scores to predict operative mortality was evaluated in subjects enrolled in the Interagency Registry of Mechanically Assisted Circulatory Support (INTERMACS), and results were compared with those from the UMHS cohort. The mean±SD MELD scores for the UMHS (n=211) and INTERMACS (n=324) cohorts were 13.7±6.1 and 15.2±5.8, respectively, with 29 (14%) and 19 (6%) perioperative deaths. In the UMHS cohort, median total perioperative blood product exposure was 74 units (25th and 75th percentiles, 44 and 120 units). Each 5-unit MELD score increase was associated with 15.1±3.8 units (β±SE) of total perioperative blood product exposure. Each 10-unit increase in total perioperative blood product exposure increased the odds of operative death (odds ratio, 1.05; 95% confidence interval, 1.01 to 1.10). Odds ratios, measuring the ability of MELD scores to predict perioperative mortality, were 1.5 (95% confidence interval, 1.1 to 2.0) and 1.5 (95% confidence interval, 1.1 to 2.1) per 5 MELD units for the UMHS and INTERMACS cohorts, respectively. When MELD scores were dichotomized as ≥17 and Conclusion— The MELD score identified left ventricular assist device candidates at high risk for perioperative bleeding and mortality.Keywords
This publication has 23 references indexed in Scilit:
- Increased Mortality, Postoperative Morbidity, and Cost After Red Blood Cell Transfusion in Patients Having Cardiac SurgeryCirculation, 2007
- Risk Factors for Mortality After Surgery in Patients With CirrhosisGastroenterology, 2007
- Change in model for end-stage liver disease score on the transplant waiting list predicts survival in patients undergoing liver transplantationTransplant International, 2006
- Preoperative characteristics and intraoperative transfusion and vasopressor requirements in patients with low vs. high MELD scoresLiver Transplantation, 2006
- Mechanical Circulatory Support Device Database of the International Society for Heart and Lung Transplantation: Third Annual Report—2005⁎ ⁎All figures and tables from this report, and a more comprehensive set of ISHLT registry slides are available at www.ishlt.org/registries/The Journal of Heart and Lung Transplantation, 2005
- Model for End-Stage Liver Disease (MELD) Predicts Nontransplant Surgical Mortality in Patients With CirrhosisAnnals of Surgery, 2005
- A Comparison of Transfusion Requirements Between Living Donation and Cadaveric Donation Liver Transplantation: Relationship to Model of End-Stage Liver Disease Score and Baseline Coagulation StatusAnesthesia & Analgesia, 2005
- A Model to Predict Survival in Patients With End–Stage Liver DiseaseHepatology, 2001
- A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shuntsHepatology, 2000
- Use of aprotinin in LVAD recipients reduces blood loss, blood use, and perioperative mortalityThe Annals of Thoracic Surgery, 1995